Cargando…

Clinical Pathological Features and Current Animal Models of Type 3 Macular Neovascularization

Type 3 macular neovascularization (MNV3), or retinal angiomatous proliferation (RAP), is a distinct type of neovascular age-related macular degeneration (AMD), which is a leading cause of vision loss in older persons. During the past decade, systematic investigation into the clinical, multimodal ima...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiang, Wei, Wei, Ran, Chen, Yongjiang, Chen, Danian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427186/ https://www.ncbi.nlm.nih.gov/pubmed/34512255 http://dx.doi.org/10.3389/fnins.2021.734860

Ejemplares similares

The heterogeneity of astrocytes in glaucoma
por: Tang, Yunjing, et al.
Publicado: (2022)

Interaction Between Mesenchymal Stem Cells and Retinal Degenerative Microenvironment
por: Lin, Yu, et al.
Publicado: (2021)

Impact of macular fluid features on outcomes of anti-vascular endothelial growth factor treatment for type 3 macular neovascularization
por: Yoon, Wontae, et al.
Publicado: (2021)

Clinical Features of Untreated Type 2 Macular Telangiectasia and Efficacy of Anti-Vascular Endothelial Growth Factor Therapy in Macular Neovascularization
por: Çoban Karataş, Müge, et al.
Publicado: (2022)

Type-3 macular neovascularization in a case of long-standing macular telangiectasia type-2
por: Chandran, Kiran, et al.
Publicado: (2023)

Type 1 Idiopathic Macular Telangiectasia Associated with Type 3 Neovascularization
por: Tilleul, Julien, et al.
Publicado: (2014)

The RAP study, report 3: Discoloration of the macular region in patients with macular neovascularization type 3
por: Haj Najeeb, Bilal, et al.
Publicado: (2021)

Clinical characteristics and visual outcome of macular hemorrhage in pathological myopia with or without choroidal neovascularization
por: Chang, Kuei-Jung, et al.
Publicado: (2016)

Treatment of neovascular age-related macular degeneration: Current therapies
por: Augustin, Albert J, et al.
Publicado: (2009)

Type 3 macular neovascularization in a patient with pentosan polysulfate maculopathy
por: Bousquet, Elodie, et al.
Publicado: (2022)

Correlation between Macular Neovascularization (MNV) Type and Druse Type in Neovascular Age-Related Macular Degeneration (AMD) Based on the CONAN Classification
por: Muth, Daniel Rudolf, et al.
Publicado: (2022)

Macular neovascularization lesion type and vision outcomes in neovascular age-related macular degeneration: post hoc analysis of HARBOR
por: Freund, K. Bailey, et al.
Publicado: (2022)

Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
por: Ahmed, Daniel, et al.
Publicado: (2020)

Automatic quantification of retinal photoreceptor integrity to predict persistent disease activity in neovascular age-related macular degeneration using deep learning
por: Song, Xian, et al.
Publicado: (2022)

Histology of Type 3 Macular Neovascularization and Microvascular Anomalies in Treated Age-Related Macular Degeneration: A Case Study
por: Berlin, Andreas, et al.
Publicado: (2023)

Full-Thickness Macular Hole Due to Choroidal Neovascularization in the Setting of Pathologic Myopia
por: Pereira, Austin, et al.
Publicado: (2022)

Blood flow pattern in eye before development of type 3 macular neovascularization
por: Yamaguchi, Saya, et al.
Publicado: (2023)

Macular neovascularization in eyes with pachydrusen
por: Teo, Kelvin Yi Chong, et al.
Publicado: (2021)

Macrophage Sult2b1 promotes pathological neovascularization in age-related macular degeneration
por: Wang, Yafang, et al.
Publicado: (2023)

Correction to: Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
por: Ahmed, Daniel, et al.
Publicado: (2020)

Choroidal and Retinal Imaging Biomarkers in Different Types of Macular Neovascularization
por: Toto, Lisa, et al.
Publicado: (2023)

Current and Future Anti-VEGF Agents for Neovascular Age-Related Macular Degeneration
por: Kaiser, Stephanie M, et al.
Publicado: (2021)

Current and Novel Therapeutic Approaches for Treatment of Neovascular Age-Related Macular Degeneration
por: ElSheikh, Reem H., et al.
Publicado: (2022)

Early OCTA Changes of Type 3 Macular Neovascularization Following Brolucizumab Intravitreal Injections
por: Gigon, Anthony, et al.
Publicado: (2022)

Association of neovascular age-related macular degeneration with migraine
por: Kuang, Tung-Mei, et al.
Publicado: (2022)

Conbercept for Treatment of Neovascular Age-Related Macular Degeneration and Visual Impairment due to Diabetic Macular Edema or Pathologic Myopia Choroidal Neovascularization: A Systematic Review and Meta-Analysis
por: Zhou, Pengxiang, et al.
Publicado: (2021)

Histology of neovascular myopic macular degeneration
por: Jonas, Shefali B., et al.
Publicado: (2021)

Spectral-domain optical coherence tomography combined with electroretinography in the assessment of conbercept for neovascular age-related macular degeneration: a preliminary study
por: Wang, Xing, et al.
Publicado: (2023)

One-year results of treat-and-extend regimen with intravitreal brolucizumab for treatment-naïve neovascular age-related macular degeneration with type 1 macular neovascularization
por: Matsumoto, Hidetaka, et al.
Publicado: (2022)

Two-year outcomes of treat-and-extend regimen with intravitreal brolucizumab for treatment-naïve neovascular age-related macular degeneration with type 1 macular neovascularization
por: Matsumoto, Hidetaka, et al.
Publicado: (2023)

Evolution of macular atrophy in eyes with neovascular age-related macular degeneration compared to fellow non-neovascular eyes
por: Blazaki, Styliani, et al.
Publicado: (2023)

Initial clinical experience of ranibizumab therapy for neovascular age-related macular degeneration
por: Rotsos, Tryfon, et al.
Publicado: (2010)

Imaging Biomarkers of 1-Year Activity in Type 1 Macular Neovascularization
por: Costanzo, Eliana, et al.
Publicado: (2021)

Intravitreal Bevacizumab for Choroidal Neovascular Membrane in Macular Telangiectasia Type 2
por: Gonzalez Martinez, Orlando G, et al.
Publicado: (2023)

Selfee, self-supervised features extraction of animal behaviors
por: Jia, Yinjun, et al.
Publicado: (2022)

VISUAL ACUITY OUTCOMES OF RANIBIZUMAB TREATMENT IN PATHOLOGIC MYOPIC EYES WITH MACULAR RETINOSCHISIS AND CHOROIDAL NEOVASCULARIZATION
por: Ceklic, Lala, et al.
Publicado: (2017)

Therapies for Neovascular Age-Related Macular Degeneration: Current Approaches and Pharmacologic Agents in Development
por: Hanout, Mostafa, et al.
Publicado: (2013)

The RAP study, report 4: morphological and topographical characteristics of multifocal macular neovascularization type 3
por: Haj Najeeb, Bilal, et al.
Publicado: (2021)

Swept Source Optical Coherence Tomography Angiography: Characteristic Findings in Type 3 Macular Neovascularization
por: Matri, Khaled El, et al.
Publicado: (2021)

Laser-induced choroidal neovascularization: A case report and some reflection on animal models for age-related macular degeneration
por: Li, Caixin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1u2ou0eajuc6360dkkje66fesj